[go: up one dir, main page]

NO20075901L - Forbindelser for immunterapi og diagnose av tuberkolose og metoder for deres anvendelse - Google Patents

Forbindelser for immunterapi og diagnose av tuberkolose og metoder for deres anvendelse

Info

Publication number
NO20075901L
NO20075901L NO20075901A NO20075901A NO20075901L NO 20075901 L NO20075901 L NO 20075901L NO 20075901 A NO20075901 A NO 20075901A NO 20075901 A NO20075901 A NO 20075901A NO 20075901 L NO20075901 L NO 20075901L
Authority
NO
Norway
Prior art keywords
tuberculosis
compounds
diagnosis
methods
immunotherapy
Prior art date
Application number
NO20075901A
Other languages
English (en)
Inventor
Yasir A Skeiky
Antonio Campos-Neto
Mark R Alderson
Davin C Dillon
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Publication of NO20075901L publication Critical patent/NO20075901L/no
Application filed by Corixa Corp filed Critical Corixa Corp

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Forbindelser og metoder for å indusere beskyttende immunitet mot tuberkulose er beskrevet. Forbindelsene tilveiebrakt inkluderer polypeptider som inneholder minst en immunogen del av en eller flere M. tuberkuloseproteiner og DNA molekyler som koder for slike polypeptider. Slike forbindelser kan bli formulert til vaksiner og/eller farmasøytiske sammensetninger for immunisering mot M. tuberkuloseinfeksjon, eller kan bli brukt for diagnose av tuberkulose.
NO20075901A 1997-05-20 2007-11-15 Forbindelser for immunterapi og diagnose av tuberkolose og metoder for deres anvendelse NO20075901L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85938197A 1997-05-20 1997-05-20
US09/073,010 US6613881B1 (en) 1997-05-20 1998-05-05 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
PCT/US1998/010407 WO1998053075A2 (en) 1997-05-20 1998-05-20 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use

Publications (1)

Publication Number Publication Date
NO20075901L true NO20075901L (no) 2000-01-18

Family

ID=26754016

Family Applications (4)

Application Number Title Priority Date Filing Date
NO19995689A NO324880B1 (no) 1997-05-20 1999-11-19 Tuberkulose-antigener og fusjonsproteiner omfattende disse, DNA som koder for antigenene og ekspresjonsvektorer og vertsceller omfattende dette DNA, samt farmasoytiske sammensetninger og vaksiner for immunoterapi og diagnose av tuberkulose.
NO20075902A NO20075902L (no) 1997-05-20 2007-11-15 Forbindelser for immunoterapi og diagnose av turberkolose og metoder for deres anvendelse
NO20075901A NO20075901L (no) 1997-05-20 2007-11-15 Forbindelser for immunterapi og diagnose av tuberkolose og metoder for deres anvendelse
NO20075900A NO20075900L (no) 1997-05-20 2007-11-15 Forbindelser for immunterapi og diagnose av tuberkulose og metoder for deres anvendelse

Family Applications Before (2)

Application Number Title Priority Date Filing Date
NO19995689A NO324880B1 (no) 1997-05-20 1999-11-19 Tuberkulose-antigener og fusjonsproteiner omfattende disse, DNA som koder for antigenene og ekspresjonsvektorer og vertsceller omfattende dette DNA, samt farmasoytiske sammensetninger og vaksiner for immunoterapi og diagnose av tuberkulose.
NO20075902A NO20075902L (no) 1997-05-20 2007-11-15 Forbindelser for immunoterapi og diagnose av turberkolose og metoder for deres anvendelse

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20075900A NO20075900L (no) 1997-05-20 2007-11-15 Forbindelser for immunterapi og diagnose av tuberkulose og metoder for deres anvendelse

Country Status (20)

Country Link
US (1) US6613881B1 (no)
EP (4) EP2172551A3 (no)
JP (4) JP4162155B2 (no)
KR (4) KR100893118B1 (no)
AT (1) ATE420180T1 (no)
AU (1) AU742751B2 (no)
BR (1) BR9809445A (no)
CA (2) CA2783134A1 (no)
CZ (2) CZ300866B6 (no)
DE (1) DE69840449D1 (no)
DK (1) DK1012293T3 (no)
ES (1) ES2321039T3 (no)
HU (1) HU226520B1 (no)
IL (2) IL133056A0 (no)
NO (4) NO324880B1 (no)
NZ (1) NZ501310A (no)
PL (1) PL191121B1 (no)
PT (1) PT1012293E (no)
TR (1) TR200000115T2 (no)
WO (1) WO1998053075A2 (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6592877B1 (en) * 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
US7087713B2 (en) 2000-02-25 2006-08-08 Corixa Corporation Compounds and methods for diagnosis and immunotherapy of tuberculosis
DE69840850D1 (de) * 1997-06-06 2009-07-09 Dynavax Tech Corp Inhibitoren von immunstimulatorischen dna sequenz aktivität
NZ504951A (en) * 1997-11-10 2001-06-29 Statens Seruminstitut Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis
WO2000026248A2 (en) 1998-11-04 2000-05-11 Isis Innovation Limited Tuberculosis diagnostic test
US20030027774A1 (en) * 1999-03-18 2003-02-06 Ronald C. Hendrickson Tuberculosis antigens and methods of use therefor
US8143386B2 (en) * 1999-04-07 2012-03-27 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
CA2378763A1 (en) 1999-07-13 2001-01-18 Statens Serum Institut Tuberculosis vaccine and diagnostics based on the mycobacterium tuberculosis esat-6 gene family
WO2001024820A1 (en) 1999-10-07 2001-04-12 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
CA2405247A1 (en) * 2000-04-19 2001-10-25 Statens Serum Institut Tuberculosis antigens and methods of use thereof
EP2133100B1 (en) * 2000-06-20 2011-10-05 Corixa Corporation MTB32A Antigen of mycobacterium tuberculosis with inactivated active site and fusion proteins thereof
WO2003070187A2 (en) * 2002-02-15 2003-08-28 Corixa Corporation Fusion proteins of mycobacterium tuberculosis
US7482116B2 (en) 2002-06-07 2009-01-27 Dna Genotek Inc. Compositions and methods for obtaining nucleic acids from sputum
WO2005118884A1 (en) * 2004-05-28 2005-12-15 The United States Of America As Represented By The Secretary Of The Navy A method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
US8475735B2 (en) * 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
CA2586620C (en) * 2004-11-16 2014-06-03 Crucell Holland B.V. Multivalent vaccines comprising recombinant viral vectors
WO2006117538A2 (en) * 2005-04-29 2006-11-09 Fusion Antibodies Limited Assays for diagnosis of tuberculosis and uses thereof
EP2305701A1 (en) 2005-07-01 2011-04-06 Forsyth Dental Infirmary for Children Tuberculosis antigen detection assays and vaccines
WO2007041539A1 (en) * 2005-09-30 2007-04-12 Transcutaneous Technologies, Inc. Iontophoresis apparatus and method for the diagnosis of tuberculosis
WO2007106560A2 (en) 2006-03-14 2007-09-20 Oregon Health & Science University Methods for detecting a mycobacterium tuberculosis infection
KR20110049834A (ko) 2008-07-25 2011-05-12 글락소스미스클라인 바이오로지칼즈 에스.에이. 투베르쿨로시스 ｒｖ2386ｃ 단백질, 이를 함유하는 조성물 및 이의 용도
LT2315597T (lt) 2008-07-25 2018-02-12 Glaxosmithkline Biologicals S.A. Naujos kompozicijos ir būdai
AU2009273130B2 (en) * 2008-07-25 2014-10-16 Glaxo Group Limited Novel compositions and methods
JP6010463B2 (ja) 2010-01-27 2016-10-19 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 改変された結核抗原
GB201012072D0 (en) * 2010-07-19 2010-09-01 Sec Dep For Environment Food A Diagnostic reagents
WO2012177656A2 (en) 2011-06-19 2012-12-27 Abogen, Inc. Devices, solutions and methods for sample collection
US12038434B2 (en) 2015-02-09 2024-07-16 DNA Genotek, Inc. Devices, solutions and methods for sample collection related applications, analysis and diagnosis

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4689397A (en) 1985-08-12 1987-08-25 Scripps Clinic And Research Foundation Synthetic polypeptides for detecting mycobacterial infections
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US4879213A (en) 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
US4952395A (en) 1987-02-26 1990-08-28 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US4976958A (en) * 1987-02-26 1990-12-11 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US6037135A (en) * 1992-08-07 2000-03-14 Epimmune Inc. Methods for making HLA binding peptides and their uses
US5330754A (en) 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
EP0736098A1 (en) * 1993-12-23 1996-10-09 Agresearch New Zealand Pastoral Agriculture Research Institute, Ltd. Mycobacteria virulence factors and a method for their identification
AU706367B2 (en) * 1995-03-13 1999-06-17 Astra Aktiebolag New DNA molecules
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
MX9801687A (es) 1995-09-01 1998-11-29 Corixa Corp Compuestos y metodos para el diagnostico de tuberculosis.
KR100433750B1 (ko) 1995-09-01 2004-09-01 코릭사 코포레이션 마이코박테리움튜베르큘로시스항원을포함하는폴리펩타이드및이를포함하는약제학적조성물
WO1998016645A2 (en) * 1996-10-11 1998-04-23 Corixa Corporation Compounds and methods for diagnosis of tuberculosis

Also Published As

Publication number Publication date
NO995689D0 (no) 1999-11-19
PT1012293E (pt) 2009-04-08
EP1012293B1 (en) 2009-01-07
CA2290774A1 (en) 1998-11-26
EP2248900A1 (en) 2010-11-10
EP2172551A2 (en) 2010-04-07
HU226520B1 (en) 2009-03-30
KR100652513B1 (ko) 2006-12-01
EP1012293A2 (en) 2000-06-28
JP4759010B2 (ja) 2011-08-31
EP2172551A3 (en) 2010-11-10
CZ410099A3 (cs) 2000-05-17
PL191121B1 (pl) 2006-03-31
HUP0003402A3 (en) 2001-03-28
IL133056A (en) 2010-11-30
TR200000115T2 (tr) 2000-11-21
KR100909640B1 (ko) 2009-07-27
KR20060066139A (ko) 2006-06-15
NO20075902L (no) 2000-01-18
AU7690798A (en) 1998-12-11
NO20075900L (no) 2000-01-18
NO995689L (no) 2000-01-18
PL337330A1 (en) 2000-08-14
US6613881B1 (en) 2003-09-02
WO1998053075A2 (en) 1998-11-26
EP2270170B1 (en) 2013-11-06
JP2002514084A (ja) 2002-05-14
IL133056A0 (en) 2001-03-19
JP2008253260A (ja) 2008-10-23
CZ300866B6 (cs) 2009-08-26
KR100924475B1 (ko) 2009-11-03
WO1998053075A3 (en) 1999-04-01
JP2008283961A (ja) 2008-11-27
BR9809445A (pt) 2000-06-13
CA2783134A1 (en) 1998-11-26
EP2248900B1 (en) 2012-07-18
CZ303194B6 (cs) 2012-05-23
KR20080036663A (ko) 2008-04-28
ES2321039T3 (es) 2009-06-01
KR20010012812A (ko) 2001-02-26
KR100893118B1 (ko) 2009-04-14
NZ501310A (en) 2001-09-28
NO324880B1 (no) 2007-12-27
ATE420180T1 (de) 2009-01-15
HUP0003402A2 (hu) 2000-12-28
JP4759011B2 (ja) 2011-08-31
JP4764445B2 (ja) 2011-09-07
KR20070026886A (ko) 2007-03-08
JP4162155B2 (ja) 2008-10-08
AU742751B2 (en) 2002-01-10
DE69840449D1 (de) 2009-02-26
JP2008245644A (ja) 2008-10-16
DK1012293T3 (da) 2009-05-04
EP2270170A1 (en) 2011-01-05

Similar Documents

Publication Publication Date Title
NO20075901L (no) Forbindelser for immunterapi og diagnose av tuberkolose og metoder for deres anvendelse
NO991694L (no) Forbindelser og metoder for immunoterapi og diagnose av tuberkulose
NO980883D0 (no) Forbindelser og fremgangsmåter for immunterapi og diagnose av tuberkulose
WO1999042076A3 (en) Compounds and methods for immunotherapy and diagnosis of tuberculosis
WO2002024739A3 (en) Spas-1 cancer antigen
CY1108864T1 (el) Ενωσεις για ανοσοθεραπεια και διαγνωση φυματιωσης και μεθοδοι χρησεις τους
AR010517A1 (es) Compuestos y metodos para la inmunoterapia y diagnostico de tuberculosis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application